Polyglycolic Acid (PGA) Market

By Type;

Coated and Uncoated

By Form;

Fibers, Films, and Others

By Process;

Direct Polycondensation of Lactic & Glycolic Acids, Ring-Opening Polymerization of the Cyclic Lactide, and Glycolide Dimers

By Application;

Drug Delivery, Tissue Engineering, Regeneration of Phrenic Nerve, and Others

By End User;

Medical, Oil & Gas, Packaging, Textile, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn929270605 Published Date: September, 2025 Updated Date: October, 2025

Polyglycolic Acid (PGA) Market Overview

Polyglycolic Acid (PGA) Market (USD Million)

Polyglycolic Acid (PGA) Market was valued at USD 5,938.91 million in the year 2024. The size of this market is expected to increase to USD 10,445.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.4%.


Polyglycolic Acid (PGA) Market

*Market size in USD million

CAGR 8.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)8.4 %
Market Size (2024)USD 5,938.91 Million
Market Size (2031)USD 10,445.08 Million
Market ConcentrationMedium
Report Pages366
5,938.91
2024
10,445.08
2031

Major Players

  • Kureha Corporation
  • Corbion, Shenzhen Polymtek Biomaterial Co. Ltd
  • BMG Incorporated
  • HuizhoForyou Medical Devices Co. Ltd
  • Teleflex
  • EI du Pont de Nemours
  • Foster Corporation
  • Samyang Biopharmaceuticals
  • Meta Biomed Co. Ltd

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Polyglycolic Acid (PGA) Market

Fragmented - Highly competitive market without dominant players


The Polyglycolic Acid (PGA) Market is expanding steadily, driven by the growing preference for biodegradable and high-performance polymers. Recognized for its superior strength and fast hydrolysis rate, more than 55% of PGA demand comes from medical uses such as sutures and implants. Its eco-friendly profile ensures broad acceptance across industries.

Medical Sector Leadership
The medical industry dominates PGA consumption, with nearly 60% of usage focused on bioabsorbable sutures, tissue engineering, and drug delivery systems. Its biocompatibility and safe degradability make it an ideal material for next-generation biomedical innovations. Rising demand for advanced medical materials continues to strengthen its adoption.

Diverse Industrial Applications
Industrial usage accounts for around 25% of total PGA demand, particularly in oil & gas and sustainable packaging. In energy exploration, PGA provides temporary support structures, while in packaging it serves as a biodegradable substitute for conventional plastics. This adaptability highlights its importance across diverse industries.

Innovation Enhancing Performance
Advancements in polymer development have led to up to 40% improvements in strength and stability for PGA. These enhancements extend its performance in challenging applications while maintaining biodegradability. Continuous R&D efforts are ensuring that PGA remains a leading option in sustainable polymer technologies.

Strong Market Prospects
The future of the PGA market looks promising, with over 50% of producers prioritizing bio-based polymers. Rising focus on sustainability and expanding use in healthcare ensure strong growth potential. With its versatility, eco-friendly properties, and reliability, PGA is positioned as a critical material in the evolution of polymer science.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Form
    3. Market Snapshot, By Process
    4. Market Snapshot, By Application
    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Polyglycolic Acid (PGA) Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Innovation in Applications
        2. Increasing Demand
        3. Technological Advancements
      2. Restraints
        1. High Production Costs
        2. Environmental Concerns
        3. Regulatory Challenges
      3. Opportunities
        1. Emerging Economies
        2. Biomedical Applications
        3. Sustainable Solutions
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Compititive Rivalry
  5. Market Segmentation
    1. Polyglycolic Acid (PGA) Market, By Type, 2021 - 2031 (USD Million)
      1. Coated
      2. Uncoated
    2. Polyglycolic Acid (PGA) Market, By Form, 2021 - 2031 (USD Million)
      1. Fibers
      2. Films
      3. Others
    3. Polyglycolic Acid (PGA) Market, By Process, 2021 - 2031 (USD Million)
      1. Direct Polycondensation of Lactic & Glycolic Acids
      2. Ring-Opening Polymerization of the Cyclic Lactide
      3. Glycolide Dimers
    4. Polyglycolic Acid (PGA) Market, By Application, 2021 - 2031 (USD Million)
      1. Drug Delivery
      2. Tissue Engineering
      3. Regeneration of Phrenic Nerve
      4. Others
    5. Polyglycolic Acid (PGA) Market, By End User, 2021 - 2031 (USD Million)
      1. Medical
      2. Oil & Gas
      3. Packaging
      4. Textile
      5. Others
    6. Polyglycolic Acid (PGA) Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Kureha Corporation
      2. Corbion, Shenzhen Polymtek Biomaterial Co. Ltd
      3. BMG Incorporated
      4. HuizhoForyou Medical Devices Co. Ltd
      5. Teleflex
      6. EI du Pont de Nemours
      7. Foster Corporation
      8. Samyang Biopharmaceuticals
      9. Meta Biomed Co. Ltd
  7. Analyst Views
  8. Future Outlook of the Market